RESUMEN
The antiviral innate immune response mainly involves type I interferon (IFN) in mammalian cells. The contribution of the RNA silencing machinery remains to be established, but several recent studies indicate that the ribonuclease DICER can generate viral siRNAs in specific conditions. It has also been proposed that type I IFN and RNA silencing could be mutually exclusive antiviral responses. In order to decipher the implication of DICER during infection of human cells with alphaviruses such as the Sindbis virus and Semliki forest virus, we determined its interactome by proteomics analysis. We show that DICER specifically interacts with several double-stranded RNA binding proteins and RNA helicases during viral infection. In particular, proteins such as DHX9, ADAR-1 and the protein kinase RNA-activated (PKR) are enriched with DICER in virus-infected cells. We demonstrate that the helicase domain of DICER is essential for this interaction and that its deletion confers antiviral properties to this protein in an RNAi-independent, PKR-dependent, manner.
Asunto(s)
Infecciones por Alphavirus/tratamiento farmacológico , Antivirales/farmacología , ARN Helicasas DEAD-box/metabolismo , Dominios y Motivos de Interacción de Proteínas/efectos de los fármacos , Ribonucleasa III/metabolismo , Virus de los Bosques Semliki/efectos de los fármacos , Replicación Viral , eIF-2 Quinasa/metabolismo , Infecciones por Alphavirus/metabolismo , Infecciones por Alphavirus/patología , ARN Helicasas DEAD-box/genética , Células HEK293 , Humanos , Interferón Tipo I/farmacología , Ribonucleasa III/genética , eIF-2 Quinasa/genéticaRESUMEN
Alphaviruses are arthropod-borne, positive-stranded RNA viruses capable of causing severe disease with high morbidity. Chikungunya virus (CHIKV) is an alphavirus that causes a febrile illness which can progress into chronic arthralgia. The current lack of vaccines and specific treatment for CHIKV infection underscores the need to develop new therapeutic interventions. To discover new antiviral agents, we performed a compound screen in cell culture-based infection models and identified two carbocyclic adenosine analogues, 6'-ß-fluoro-homoaristeromycin (FHA) and 6'-fluoro-homoneplanocin A (FHNA), that displayed potent activity against CHIKV and Semliki Forest virus (SFV) with 50% effective concentrations in the nanomolar range at nontoxic concentrations. The compounds, designed as inhibitors of the host enzyme S-adenosylhomocysteine (SAH) hydrolase, impeded postentry steps in CHIKV and SFV replication. Selection of FHNA-resistant mutants and reverse genetics studies demonstrated that the combination of mutations G230R and K299E in CHIKV nonstructural protein 1 (nsP1) conferred resistance to the compounds. Enzymatic assays with purified wild-type (wt) SFV nsP1 suggested that an oxidized (3'-keto) form, rather than FHNA itself, directly inhibited the MTase activity, while a mutant protein with the K231R and K299E substitutions was insensitive to the compound. Both wt nsP1 and the resistant mutant were equally sensitive to the inhibitory effect of SAH. Our combined data suggest that FHA and FHNA inhibit CHIKV and SFV replication by directly targeting the MTase activity of nsP1, rather than through an indirect effect on host SAH hydrolase. The high potency and selectivity of these novel alphavirus mRNA capping inhibitors warrant further preclinical investigation of these compounds.
Asunto(s)
Adenosina/análogos & derivados , Antivirales/farmacología , Virus Chikungunya/efectos de los fármacos , Virus Chikungunya/fisiología , Adenosina/farmacología , Animales , Virus Chikungunya/patogenicidad , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Farmacorresistencia Viral/efectos de los fármacos , Farmacorresistencia Viral/genética , Guanosina Monofosfato/metabolismo , Mutación , Radioisótopos de Fósforo , Virus de los Bosques Semliki/efectos de los fármacos , Células Vero , Proteínas no Estructurales Virales/antagonistas & inhibidores , Proteínas no Estructurales Virales/genética , Proteínas no Estructurales Virales/metabolismo , Replicación Viral/efectos de los fármacosRESUMEN
Interferons (IFNs) direct innate and acquired immune responses and, accordingly, are used therapeutically to treat a number of diseases, yet the diverse effects they elicit are not fully understood. Here, we identified the promyelocytic leukemia zinc finger (PLZF) protein as a previously unrecognized component of the IFN response. IFN stimulated an association of PLZF with promyelocytic leukemia protein (PML) and histone deacetylase 1 (HDAC1) to induce a decisive subset of IFN-stimulated genes (ISGs). Consequently, PLZF-deficient mice had a specific ISG expression defect and as a result were more susceptible to viral infection. This susceptibility correlated with a marked decrease in the expression of the key antiviral mediators and an impaired IFN-mediated induction of natural killer cell function. These results provide new insights into the regulatory mechanisms of IFN signaling and the induction of innate antiviral immunity.
Asunto(s)
Infecciones por Alphavirus/inmunología , Inmunidad Innata/genética , Interferón-alfa/inmunología , Células Asesinas Naturales/inmunología , Factores de Transcripción de Tipo Kruppel/metabolismo , Infecciones por Alphavirus/genética , Infecciones por Alphavirus/virología , Animales , Línea Celular Tumoral , Fibroblastos/efectos de los fármacos , Fibroblastos/inmunología , Fibroblastos/virología , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Histona Desacetilasa 1 , Histona Desacetilasas/inmunología , Histona Desacetilasas/metabolismo , Interferón-alfa/farmacología , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/metabolismo , Factores de Transcripción de Tipo Kruppel/genética , Factores de Transcripción de Tipo Kruppel/inmunología , Ratones , Ratones Noqueados , Análisis de Secuencia por Matrices de Oligonucleótidos , Proteína de la Leucemia Promielocítica con Dedos de Zinc , Virus de los Bosques Semliki/efectos de los fármacos , Virus de los Bosques Semliki/inmunología , Transducción de Señal/genética , Transducción de Señal/inmunologíaRESUMEN
As new pathogenic viruses continue to emerge, it is paramount to have intervention strategies that target a common denominator in these pathogens. The fusion of viral and cellular membranes during viral entry is one such process that is used by many pathogenic viruses, including chikungunya virus, West Nile virus, and influenza virus. Obatoclax, a small-molecule antagonist of the Bcl-2 family of proteins, was previously determined to have activity against influenza A virus and also Sindbis virus. Here, we report it to be active against alphaviruses, like chikungunya virus (50% effective concentration [EC50] = 0.03 µM) and Semliki Forest virus (SFV; EC50 = 0.11 µM). Obatoclax inhibited viral entry processes in an SFV temperature-sensitive mutant entry assay. A neutral red retention assay revealed that obatoclax induces the rapid neutralization of the acidic environment of endolysosomal vesicles and thereby most likely inhibits viral fusion. Characterization of escape mutants revealed that the L369I mutation in the SFV E1 fusion protein was sufficient to confer partial resistance against obatoclax. Other inhibitors that target the Bcl-2 family of antiapoptotic proteins inhibited neither viral entry nor endolysosomal acidification, suggesting that the antiviral mechanism of obatoclax does not depend on its anticancer targets. Obatoclax inhibited the growth of flaviviruses, like Zika virus, West Nile virus, and yellow fever virus, which require low pH for fusion, but not that of pH-independent picornaviruses, like coxsackievirus A9, echovirus 6, and echovirus 7. In conclusion, obatoclax is a novel inhibitor of endosomal acidification that prevents viral fusion and that could be pursued as a potential broad-spectrum antiviral candidate.
Asunto(s)
Antivirales/farmacología , Virus Chikungunya/efectos de los fármacos , Endosomas/efectos de los fármacos , Lisosomas/efectos de los fármacos , Fusión de Membrana/efectos de los fármacos , Pirroles/farmacología , Virus de los Bosques Semliki/efectos de los fármacos , Animales , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/virología , Virus Chikungunya/genética , Virus Chikungunya/crecimiento & desarrollo , Cricetinae , Farmacorresistencia Viral/genética , Endosomas/metabolismo , Células Epiteliales/efectos de los fármacos , Células Epiteliales/virología , Expresión Génica , Hepatocitos/efectos de los fármacos , Hepatocitos/virología , Humanos , Concentración de Iones de Hidrógeno/efectos de los fármacos , Indoles , Lisosomas/metabolismo , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Mutación , Rojo Neutro/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Virus de los Bosques Semliki/genética , Virus de los Bosques Semliki/crecimiento & desarrollo , Proteínas del Envoltorio Viral/genética , Proteínas del Envoltorio Viral/metabolismo , Internalización del Virus/efectos de los fármacos , Replicación Viral/efectos de los fármacos , Virus del Nilo Occidental/efectos de los fármacos , Virus del Nilo Occidental/genética , Virus del Nilo Occidental/crecimiento & desarrollo , Virus de la Fiebre Amarilla/efectos de los fármacos , Virus de la Fiebre Amarilla/genética , Virus de la Fiebre Amarilla/crecimiento & desarrollo , Virus Zika/efectos de los fármacos , Virus Zika/genética , Virus Zika/crecimiento & desarrolloRESUMEN
In an effort to identify new potent and selective inhibitors of chikungunya virus and HIV-1 and HIV-2 virus replication, the endemic Mascarene species Stillingia lineata was investigated. LC/MS and bioassay-guided purification of the EtOAc leaf extract using a chikungunya virus-cell-based assay led to the isolation of six new (4-9) and three known (1-3) tonantzitlolones possessing the rare C20-flexibilane skeleton, along with tonantzitloic acid (10), a new linear diterpenoid, and three new (11, 13, and 15) and two known (12 and 14) tigliane-type diterpenoids. The planar structures of the new compounds and their relative configurations were determined by spectroscopic analysis, and their absolute configurations were determined through comparison with literature data and from biogenetic considerations. These compounds were investigated for selective antiviral activity against chikungunya virus (CHIKV), Semliki Forest virus, Sindbis virus, and, for compounds 11-15, the HIV-1 and HIV-2 viruses. Compounds 12-15 were found to be the most potent and are selective inhibitors of CHIKV, HIV-1, and HIV-2 replication. In particular, compound 14 inhibited CHIKV replication with an EC50 value of 1.2 µM on CHIKV and a selectivity index of >240, while compound 15 inhibited HIV-1 and HIV-2 with EC50 values of 0.043 and 0.018 µM, respectively. It was demonstrated further that potency and selectivity are sensitive to the substitution pattern on the tigliane skeleton. The cytotoxic activities of compounds 1-10 were evaluated against the HCT-116, MCF-7, and PC3 cancer cell lines.
Asunto(s)
Antivirales/aislamiento & purificación , Antivirales/farmacología , Diterpenos/aislamiento & purificación , Diterpenos/farmacología , Euphorbiaceae/química , Antivirales/química , Virus Chikungunya/efectos de los fármacos , Diterpenos/química , Francia , Células HCT116 , VIH-1/efectos de los fármacos , VIH-2/efectos de los fármacos , Humanos , Células MCF-7 , Compuestos Macrocíclicos/farmacología , Estructura Molecular , Virus de los Bosques Semliki/efectos de los fármacos , Virus Sindbis/efectos de los fármacos , Replicación Viral/efectos de los fármacosRESUMEN
We present two facile approaches for introducing multivalent displays of tyrosine sulfate mimetic ligands on the surface of cellulose nanocrystals (CNCs) for application as viral inhibitors. We tested the efficacy of cellulose nanocrystals, prepared either from cotton fibers or Whatman filter paper, to inhibit alphavirus infectivity in Vero (B) cells. Cellulose nanocrystals were produced by sulfuric acid hydrolysis leading to nanocrystal surfaces decorated with anionic sulfate groups. When the fluorescent marker expressing Semliki Forest virus vector, VA7-EGFP, was incubated with CNCs, strong inhibition of virus infectivity was achieved, up to 100 and 88% for cotton and Whatman CNCs, respectively. When surface sulfate groups of CNCs were exchanged for tyrosine sulfate mimetic groups (i.e. phenyl sulfonates), improved viral inhibition was attained. Our observations suggest that the conjugation of target-specific functionalities to CNC surfaces provides a means to control their antiviral activity. Multivalent CNCs did not cause observable in vitro cytotoxicity to Vero (B) cells or human corneal epithelial (HCE-T) cells, even within the 100% virus-inhibitory concentrations. Based on the similar chemistry of known polyanionic inhibitors, our results suggest the potential application of CNCs as inhibitors of other viruses, such as human immunodeficiency virus (HIV) and herpes simplex viruses.
Asunto(s)
Infecciones por Alphavirus/tratamiento farmacológico , Antivirales/química , Antivirales/farmacología , Celulosa/síntesis química , Nanopartículas/química , Nanotecnología/métodos , Virus de los Bosques Semliki/efectos de los fármacos , Tirosina/análogos & derivados , Animales , Biomimética , Celulosa/química , Chlorocebus aethiops , Epitelio Corneal/citología , Epitelio Corneal/efectos de los fármacos , Genes erbB-1 , Ligandos , Nanopartículas/toxicidad , Virus de los Bosques Semliki/genética , Espectroscopía Infrarroja por Transformada de Fourier , Tirosina/química , Células Vero/efectos de los fármacos , Células Vero/virologíaRESUMEN
Bioassay-guided purification of an EtOAc extract of the whole plant of Euphorbia amygdaloides ssp. semiperfoliata using a chikungunya virus-cell-based assay led to the isolation of six new (1-4, 9, and 10) and six known (5-7, 8, 11, and 12) jatrophane esters. Their planar structures and relative configurations were determined by extensive spectroscopic analysis, and their absolute configurations by X-ray analysis. These compounds were investigated for selective antiviral activity against chikungunya virus (CHIKV), Semliki Forest virus, Sindbis virus, and HIV-1 and HIV-2 viruses. Compound 3 was found to be the most potent and selective inhibitor of the replication of CHIKV and of HIV-1 and HIV-2 (EC50 = 0.76, IC50 = 0.34 and 0.043 µM, respectively). A preliminary structure-activity relationship study demonstrated that potency and selectivity are very sensitive to the substitution pattern on the jatrophane skeleton. Although replication strategies of CHIK and HIV viruses are quite different, the mechanism of action by which these compounds act may involve a similar target for both viruses. The present results provide additional support for a previous hypothesis that the anti-CHIKV activity could involve a PKC-dependent mechanism.
Asunto(s)
Infecciones por Alphavirus/tratamiento farmacológico , Antivirales/aislamiento & purificación , Virus Chikungunya/efectos de los fármacos , Diterpenos/aislamiento & purificación , Diterpenos/farmacología , Euphorbia/química , Antivirales/química , Antivirales/farmacología , Fiebre Chikungunya , Diterpenos/química , Francia , VIH-1/efectos de los fármacos , VIH-2/efectos de los fármacos , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular , Virus de los Bosques Semliki/efectos de los fármacos , Virus Sindbis/efectos de los fármacos , Relación Estructura-Actividad , Replicación Viral/efectos de los fármacosRESUMEN
BACKGROUND: RNA interference (RNAi) is a target-specific gene silencing method that can be used to determine gene functions and investigate host-pathogen interactions, as well as facilitating the development of ecofriendly pesticides. Commercially available transfection reagents (TRs) can improve the efficacy of RNAi. However, we currently lack a product and protocol for the transfection of insect cell lines with long double-stranded RNA (dsRNA). METHODS: We used agarose gel electrophoresis to determine the capacity of eight TRs to form complexes with long dsRNA. A CellTiter-Glo assay was then used to assess the cytotoxicity of the resulting lipoplexes. We also measured the cellular uptake of dsRNA by fluorescence microscopy using the fluorophore Cy3 as a label. Finally, we analyzed the TRs based on their transfection efficacy and compared the RNAi responses of Aedes albopictus C6/36 and U4.4 cells by knocking down an mCherry reporter Semliki Forest virus in both cell lines. RESULTS: The TRs from Biontex (K4, Metafectene Pro, and Metafectene SI+) showed the best complexing capacity and the lowest dsRNA:TR ratio needed for complete complex formation. Only HiPerFect was unable to complex the dsRNA completely, even at a ratio of 1:9. Most of the complexes containing mCherry-dsRNA were nontoxic at 2 ng/µL, but Lipofectamine 2000 was toxic at 1 ng/µL in U4.4 cells and at 2 ng/µL in C6/36 cells. The transfection of U4.4 cells with mCherry-dsRNA/TR complexes achieved significant knockdown of the virus reporter. Comparison of the RNAi response in C6/36 and U4.4 cells suggested that C6/36 cells lack the antiviral RNAi response because there was no significant knockdown of the virus reporter in any of the treatments. CONCLUSIONS: C6/36 cells have an impaired RNAi response as previously reported. This investigation provides valuable information for future RNAi experiments by showing how to mitigate the adverse effects attributed to TRs. This will facilitate the judicious selection of TRs and transfection conditions conducive to RNAi research in mosquitoes.
Asunto(s)
Aedes , Interferencia de ARN , ARN Bicatenario , Transfección , ARN Bicatenario/genética , ARN Bicatenario/metabolismo , Animales , Línea Celular , Aedes/genética , Silenciador del Gen , Virus de los Bosques Semliki/genética , Virus de los Bosques Semliki/efectos de los fármacosRESUMEN
The enveloped alphaviruses infect cells via a low-pH-triggered membrane fusion reaction mediated by the viral transmembrane protein E1. During fusion, E1 inserts into the target membrane and refolds to a hairpin-like postfusion conformation in which domain III (DIII) and the juxtamembrane stem pack against a central core trimer. Although zinc has previously been shown to cause a striking block in alphavirus fusion with liposome target membranes, the mechanism of zinc's effect on the E1 fusion protein is not understood. Here we developed a cell culture system to study zinc inhibition of fusion and infection of the alphavirus Semliki Forest virus (SFV). Inclusion of 2 mM ZnCl(2) in the pH 5.75 fusion buffer caused a decrease of â¼5 logs in SFV fusion at the plasma membrane. Fusion was also inhibited by nickel, a chemically related transition metal. Selection for SFV zinc resistance identified a key histidine residue, H333 on E1 DIII, while other conserved E1 histidine residues were not involved. An H333N mutation conferred resistance to both zinc and nickel, with properties in keeping with the known pH-dependent chelation of these metals by histidine. Biochemical studies demonstrated that zinc strongly inhibits formation of the postfusion E1 trimer in wild-type SFV but not in an H333 mutant. Together our results suggest that zinc acts by blocking the fold-back of DIII via its interaction with H333.
Asunto(s)
Infecciones por Alphavirus/virología , Regulación hacia Abajo/efectos de los fármacos , Virus de los Bosques Semliki/efectos de los fármacos , Virus de los Bosques Semliki/fisiología , Proteínas Virales de Fusión/química , Proteínas Virales de Fusión/metabolismo , Internalización del Virus/efectos de los fármacos , Zinc/farmacología , Animales , Línea Celular , Cricetinae , Humanos , Estructura Terciaria de Proteína , Virus de los Bosques Semliki/química , Virus de los Bosques Semliki/genética , Proteínas Virales de Fusión/genéticaRESUMEN
Repurposing drugs is a promising strategy to identify therapeutic interventions against novel and re-emerging viruses. Posaconazole is an antifungal drug used to treat invasive aspergillosis and candidiasis. Recently, posaconazole and its structural analog, itraconazole were shown to inhibit replication of multiple viruses by modifying intracellular cholesterol homeostasis. Here, we show that posaconazole inhibits replication of the alphaviruses Semliki Forest virus (SFV), Sindbis virus and chikungunya virus with EC50 values ranging from 1.4 µM to 9.5 µM. Posaconazole treatment led to a significant reduction of virus entry in an assay using a temperature-sensitive SFV mutant, but time-of-addition and RNA transfection assays indicated that posaconazole also inhibits post-entry stages of the viral replication cycle. Virus replication in the presence of posaconazole was partially rescued by the addition of exogenous cholesterol. A transferrin uptake assay revealed that posaconazole considerably slowed down cellular endocytosis. A single point mutation in the SFV E2 glycoprotein, H255R, provided partial resistance to posaconazole as well as to methyl-ß-cyclodextrin, corroborating the effect of posaconazole on cholesterol and viral entry. Our results indicate that posaconazole inhibits multiple steps of the alphavirus replication cycle and broaden the spectrum of viruses that can be targeted in vitro by posaconazole, which could be further explored as a therapeutic agent against emerging viruses.
Asunto(s)
Alphavirus/efectos de los fármacos , Antivirales/farmacología , Reposicionamiento de Medicamentos/métodos , Triazoles/farmacología , Replicación Viral/efectos de los fármacos , Alphavirus/clasificación , Animales , Línea Celular , Virus Chikungunya/efectos de los fármacos , Chlorocebus aethiops , Cricetinae , Endocitosis/efectos de los fármacos , Humanos , Virus de los Bosques Semliki/efectos de los fármacos , Virus Sindbis/efectos de los fármacos , Células Vero , Internalización del Virus/efectos de los fármacosRESUMEN
The present findings indicate that the wide fluctuation observed in the antiviral activity of various crude helenine preparations may be attributable to the presence of varying amounts of inhibitor. Antiviral activity could be enhanced by removal of the inhibitor. A meaningful value for helenine titer in a preparation clearly should be determined in the inhibitor-free zone.
Asunto(s)
Antibacterianos/farmacología , Antivirales/farmacología , Penicillium , Técnicas In Vitro , Virus de los Bosques Semliki/efectos de los fármacosRESUMEN
The pathway by which semliki forest virus (SFV), a membrane-containing animal virus, enters BHK-21 cells was studied morphologically and biochemically. After attaching to the cell surface, the majority of viruses was rapidly trapped into coated pits, internalized by endocytosis in coated vesicles, and sequestered into intracellular vacuoles and lysosomes. Direct penetration of viruses through the plasma membrane was never observed. To assess the possible involvement of lysosomes in the release of the genome into the cytoplasm, the effect of five lysosomotropic agents, known to increase the lysosomal pH, was tested. All of these agents inhibited SFV infectivity and one, chloroquine (the agent studied in most detail), inhibited a very early step in the infection but had no effect on binding, endocytosis, or intracellular distribution of SFV. Thus, the inhibitory effect was concluded to be either on penetration of the nucelocapsid into the cytoplasm or on uncoating of the viral RNA. Possible mechanisms for the penetration of the genome into the cytoplasm were studied in vitro, using phospholipids-cholesterol liposomes and isolated SFV. When the pH was 6.0 or lower, efficient fusion of the viral membranes and the liposomal membranes occurred, resulting in the transfer of the nucleocapsid into the liposomes. Infection of cells could also be induced by brief low pH treatment of cells with bound SFV under conditions where the normal infection route was blocked. The results suggest that the penetration of the viral genome into the cytosol takes place intracellularly through fusion between the limiting membrane of intracellular vacuoles and the membrane of viruses contained within them. The low pH required for fusion together with the inhibitory effect of lysosomotropic agents implicate lysosomes, or other intracellular vacuoles with sufficiently low pH, as the main sites of penetration.
Asunto(s)
Membrana Celular/microbiología , Virus de los Bosques Semliki/crecimiento & desarrollo , Adsorción , Animales , Línea Celular , Cloroquina/farmacología , Cricetinae , Endocitosis , Técnica del Anticuerpo Fluorescente , Riñón , Lisosomas/microbiología , Microvellosidades/microbiología , Receptores Virales , Virus de los Bosques Semliki/efectos de los fármacos , Replicación Viral/efectos de los fármacosRESUMEN
Tilorone hydrochloride, 2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one dihydrochloride, given orally to mice before they are infected is active against at least nine viruses of both RNA and DNA groups. The compound is effective when given prophylactically; the optimum time of treatment depends on the route of infection.
Asunto(s)
Antivirales/uso terapéutico , Encefalitis/tratamiento farmacológico , Fluorenos/uso terapéutico , Herpes Simple/tratamiento farmacológico , Miocarditis/tratamiento farmacológico , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Virosis/tratamiento farmacológico , Administración Oral , Animales , Antivirales/administración & dosificación , Virus de la Encefalomiocarditis/efectos de los fármacos , Ratones , Virus de los Bosques Semliki/efectos de los fármacos , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacosRESUMEN
Virazole is a synthetic nucleoside active in tissue culture against at least 16 DNA and RNA viruses. Applied topically, it inhibits herpetic keratitis in rabbits and tail lesions induced by herpes, vaccinia, and vesicular stomatitis viruses in mice. Injected intraperitoneally into mice, it inhibits splenomegaly and hepatomegaly induced by Friend leukemia virus and respiratory infections caused by influenza A(O), A(2), and B viruses and parainfluenza 1 virus. infections is also effective.
Asunto(s)
Antivirales , Virus ADN/efectos de los fármacos , Nucleósidos/farmacología , Virus ARN/efectos de los fármacos , Adenoviridae/efectos de los fármacos , Amidas/farmacología , Animales , Células Cultivadas , Citomegalovirus/efectos de los fármacos , Virus de la Leucemia Murina de Friend/efectos de los fármacos , Ratones , Pruebas de Sensibilidad Microbiana , Orthomyxoviridae/efectos de los fármacos , Poliovirus/efectos de los fármacos , Conejos , Virus de la Rabia/efectos de los fármacos , Respirovirus/efectos de los fármacos , Rhinovirus/efectos de los fármacos , Ribonucleósidos/farmacología , Ribonucleósidos/uso terapéutico , Virus de los Bosques Semliki/efectos de los fármacos , Triazoles/farmacología , Virus Vaccinia/efectos de los fármacos , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacos , Virosis/tratamiento farmacológicoRESUMEN
This paper describes inhibition of Semliki Forest virus (SFV) replication by synthetic derivatives of naturally occurring triterpenoid betulin (1). Chemical modifications were made to OH groups at C-3 and C-28 and to the C-20-C-29 double bond. A set of heterocyclic betulin derivatives was also assayed. A free or acetylated OH group at C-3 was identified as an important structural contributor for anti-SFV activity, 3,28-di-O-acetylbetulin (4) being the most potent derivative (IC50 value 9.1 microM). Betulinic acid (13), 28-O-tetrahydropyranylbetulin (17), and a triazolidine derivative (41) were also shown to inhibit Sindbis virus, with IC50 values of 0.5, 1.9, and 6.1 microM, respectively. The latter three compounds also had significant synergistic effects against SFV when combined with 3'-amino-3'-deoxyadenosine. In contrast to previous work on other viruses, the antiviral activity of 13 was mapped to take place in virus replication phase. The efficacy was also shown to be independent of external guanosine supplementation.
Asunto(s)
Virus de los Bosques Semliki/efectos de los fármacos , Triterpenos/síntesis química , Triterpenos/farmacología , Replicación Viral/efectos de los fármacos , Guanosina/farmacología , Estructura Molecular , Triterpenos Pentacíclicos , Virus Sindbis/efectos de los fármacos , Triterpenos/química , Ácido BetulínicoRESUMEN
Semliki forest virus (SFV) is a pathogen causing lethal encephalitis in laboratory mice. In this study, we obtained three short hairpin RNAs (shRNAs) which could specifically target SFV sequence in GFP reporting systems and effectively suppress SFV replication in luciferase-containing reporter virus system. At a multiplicity of infection (MOI) of 0.001, the luciferase reporter activity was reduced by 78-92% by shRNA expression plasmids and virus yields reduced 2 to 10-fold at 20 h post-infection. When lentiviral vector-derived shRNAs were employed, the virus titers decreased 8 to 126-fold at 24 h post-infection and 6 to 19-fold at 48 h post-infection and the cell survival was prolonged. These data formed the basis for further in vivo studies of RNA interference in mouse models.
Asunto(s)
Antivirales/farmacología , Lentivirus/genética , ARN Interferente Pequeño/farmacología , Virus de los Bosques Semliki/efectos de los fármacos , Virus de los Bosques Semliki/fisiología , Replicación Viral , Animales , Línea Celular , Supervivencia Celular , Cricetinae , Genes Reporteros , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Luciferasas/genética , Luciferasas/metabolismo , Plásmidos , ARN Interferente Pequeño/genética , Virus de los Bosques Semliki/genéticaRESUMEN
Several members of the widespread alphavirus group are pathogenic, but no therapy is available to treat these RNA virus infections. We report here a quantitative assay to screen for inhibitors of Semliki Forest virus (SFV) replication, and demonstrate the effects of 29 nucleosides on SFV and Sindbis virus replication. The anti-SFV assay developed is based on a SFV strain containing Renilla luciferase inserted after the nsP3 coding region, yielding a marker virus in which the luciferase is cleaved out during polyprotein processing. The reporter-gene assay was miniaturized, automated and validated, resulting in a Z' value of 0.52. [3H]uridine labeling for 1 h at the maximal viral RNA synthesis time point was used as a comparative method. Anti-SFV screening and counter-screening for cell viability led to the discovery of several new SFV inhibitors. 3'-amino-3'-deoxyadenosine was the most potent inhibitor in this set, with an IC50 value of 18 microM in the reporter-gene assay and 2 microM in RNA synthesis rate detection. Besides the 3'-substituted analogues, certain N6-substituted nucleosides had similar IC50 values for both SFV and Sindbis replication, suggesting the applicability of this methodology to alphaviruses in general.
Asunto(s)
Alphavirus/efectos de los fármacos , Antivirales , Genes Reporteros , Luciferasas/metabolismo , Nucleósidos , Replicación Viral/efectos de los fármacos , Alphavirus/genética , Alphavirus/fisiología , Animales , Antivirales/química , Antivirales/farmacología , Línea Celular , Cricetinae , Desoxiadenosinas/química , Desoxiadenosinas/farmacología , Concentración 50 Inhibidora , Luciferasas/genética , Pruebas de Sensibilidad Microbiana/métodos , Nucleósidos/química , Nucleósidos/farmacología , ARN Viral/biosíntesis , Virus de los Bosques Semliki/efectos de los fármacos , Virus de los Bosques Semliki/genética , Virus de los Bosques Semliki/fisiología , Virus Sindbis/efectos de los fármacos , Virus Sindbis/genética , Virus Sindbis/fisiologíaRESUMEN
The chikungunya virus (CHIKV) is a mosquito-borne virus that belongs to the genus Alphavirus, family Togaviridae. It is the cause of chikungunya fever in humans, which presents a serious global threat due to its high rate of contagion. The clinical symptoms of CHIKV include fever and persistent, severe arthritis. Micafungin has broad-spectrum fungicidal activity against Candida spp. is a promising echinocandin that was recently approved by the U.S. Food and Drug Administration (FDA) and has demonstrated activity against Candida and Aspergillus. Recent studies have demonstrated the antiviral activity of micafungin; however, the inhibitory effects against CHIKV have yet to be investigated. Our objectives in this study were to explore the antiviral effects of micafungin on CHIKV infection and to elucidate the potential molecular mechanisms of inhibition. We determined that micafungin has the ability to counter CHIKV-induced cytopathic effects. We further discovered that micafungin limits virus replication, release, cell-to-cell transmission, and also slightly affected virus stability during high doses treatment. The efficacy of micafungin was further confirmed against two clinical isolates of CHIKV and two alphaviruses: Sindbis virus (SINV) and Semliki Forest virus (SFV). Our findings suggest that micafungin has considerable potential as a novel inhibitor against the viral replication, and intracellular and extracellular transmission of CHIKV, and has a little effect on virus stability. Our findings also suggest that micafungin could have curative effects on other alphavirus infections.
Asunto(s)
Alphavirus/efectos de los fármacos , Antivirales/farmacología , Virus Chikungunya/efectos de los fármacos , Micafungina/farmacología , Infecciones por Alphavirus/tratamiento farmacológico , Fiebre Chikungunya/tratamiento farmacológico , Fiebre Chikungunya/virología , Virus de los Bosques Semliki/efectos de los fármacos , Virus Sindbis/efectos de los fármacos , Replicación Viral/efectos de los fármacosRESUMEN
Several viruses have been demonstrated to be the etiologic agent in chronic progressive diseases, associated with persistence; however, major questions concerning the pathogenic mechanisms of viral persistence are still unanswered. With the aim of identifying host cellular proteins that may play a role in viral replication, we established long-term persistently infected human glioblastoma cell lines with mutant measles virus (MV) and analyzed the host proteins by two-dimensional gel electrophoresis (2-DE) with mass spectrometry. We observed significant down-modulation in the expression of mitochondrial short chain enoyl-CoA hydratase (ECHS), which catalyzes the beta-oxidation pathway of fatty acid. Knockdown of this gene by a short interference RNA (siRNA) apparently impaired wild-type MV replication and the cytopathic effects (CPEs) of MV were significantly reduced in siRNA-transfected cells. These findings will shed light upon a new important notion for the interaction between virus replication and lipid metabolism in host cells and might provide a new strategy for virus control.
Asunto(s)
Ácido Graso Sintasas/metabolismo , Virus del Sarampión/crecimiento & desarrollo , Proteínas Mitocondriales/metabolismo , NADH NADPH Oxidorreductasas/metabolismo , Replicación Viral , Antivirales/farmacología , Western Blotting , Carnitina O-Palmitoiltransferasa/antagonistas & inhibidores , Carnitina O-Palmitoiltransferasa/metabolismo , Línea Celular Tumoral , Regulación hacia Abajo , Electroforesis en Gel Bidimensional , Inhibidores Enzimáticos/farmacología , Compuestos Epoxi/farmacología , Ácido Graso Sintasas/genética , Glioblastoma/enzimología , Glioblastoma/patología , Glioblastoma/virología , Proteínas de Choque Térmico/metabolismo , Humanos , Interferón beta/farmacología , Virus del Sarampión/efectos de los fármacos , Virus del Sarampión/genética , Proteínas Mitocondriales/genética , Chaperonas Moleculares/metabolismo , Mutación , NADH NADPH Oxidorreductasas/genética , ARN Interferente Pequeño/genética , Virus de los Bosques Semliki/efectos de los fármacos , Virus de los Bosques Semliki/crecimiento & desarrollo , Transfección , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacos , Virus de la Estomatitis Vesicular Indiana/crecimiento & desarrolloRESUMEN
The recent outbreak of infection with Zika virus (ZIKV; Flaviviridae) has attracted attention to this previously neglected mosquito-borne pathogen and the need for efficient therapies. Since flavivirus replication is generally known to be dependent on fatty acid biosynthesis, two inhibitors of this pathway, 5-(tetradecyloxyl)-2-furoic acid (TOFA) and cerulenin, were tested for their potentiality to inhibit virus replication. At concentrations previously shown to inhibit the replication of other flaviviruses, neither drug had a significant antiviral affect against ZIKV, but reduced the replication of the non-related mosquito-borne Semliki Forest virus (Togaviridae).